| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 10503 | 2018 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 10010 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 8247 | 2017 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 7712 | 2018 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 7283 | 2020 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The lancet 392 (10159), 1923-1994, 2018 | 6600* | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3813 | 2018 |
| A global survey of potential acceptance of a COVID-19 vaccine JV Lazarus, SC Ratzan, A Palayew, LO Gostin, HJ Larson, K Rabin, ... Nature medicine 27 (2), 225-228, 2021 | 3433 | 2021 |
| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 3183 | 2023 |
| Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018 | 1861 | 2018 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1657 | 2018 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1512 | 2020 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 1063 | 2018 |
| Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 857 | 2018 |
| Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies L Pimpin, H Cortez-Pinto, F Negro, E Corbould, JV Lazarus, L Webber, ... Journal of hepatology 69 (3), 718-735, 2018 | 838 | 2018 |
| The Lancet Commission on lessons for the future from the COVID-19 pandemic JD Sachs, SSA Karim, L Aknin, J Allen, K Brosbøl, F Colombo, GC Barron, ... The Lancet 400 (10359), 1224-1280, 2022 | 697 | 2022 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 625 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … Global Burden of Disease Cancer Collaboration JAMA oncology, 2019 | 611 | 2019 |
| Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 601 | 2022 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 579* | 2019 |
John DillonProfessor University of DundeeПотвърден имейл адрес: dundee.ac.uk